DCAT Value Chain Insights

The $74-Billion Marriage of Bristol-Myers Squibb and Celgene

Bristol-Myers Squibb completed its $74-billion acquisition of Celgene last month to form a newly combined company with eight products of over $1 billion in annual sales and near-term revenue...

2019: The Pharmaceutical Industry Year in Review

As 2019 comes to a close, what was the top news stories shaping the pharmaceutical industry? From mega acquisitions to deal-making in cell and gene therapies, to shifting supply lines from a...

A winning pediatric dosage formulation

Information
March 6, 2019
Sponsored by Cambrex

When a global pharmaceutical company’s pediatric formulation and dosage form(s) didn’t fit the plant equipment profile used to manufacture the adult dosage form at the customer’s facility, they...

Read More
Cambrex eBook - Small molecules 2.0: the bigger picture

Information
February 20, 2019
Sponsored by Cambrex

The Cambrex eBook contains 30 more thought leading articles from the world's fastest growing small molecule company. Discover the highest number of NCEs approved by the FDA.

Read More
Continuous Flow for APIs and Intermediates (Part 2)

Information
February 13, 2019
Sponsored by Cambrex

Cambrex’s Dr. Shawn Conway, Director of Engineering, R&D, outlines how continuous flow processes simplify and break through traditional method limitations to achieve efficiencies in cost, quality and...

Read More